Hassan Raza/LinkedIn
May 26, 2026, 11:05
Hassan Raza։ When the Platelet Count Lies – Think Artifact Before Disease
Hassan Raza, Consultant Hematologist and Transfusion Medicine Specialist, shared a post on LinkedIn:
“When the Platelet Count Lies: Think Artifact Before Disease
A 48-year-old man underwent routine pre-operative testing.
CBC showed:
- Platelet count: 820 × 10⁹/L
- Hemoglobin and WBC: normal
- No symptoms or history suggestive of thrombocytosis
- Patient clinically stable
However:
- Peripheral smear review shows no true increase in platelets
- Background contains numerous small particles/debris
What is the most likely explanation?
Answer: Spurious thrombocytosis due to platelet count artifact
What particles are miscounted as platelets?
Automated analyzers may misclassify particles in the platelet size range (2–20 fL), including:
- RBC fragments (schistocytes)
- Cell debris (leukocyte or erythrocyte fragments)
- Cryoglobulin / protein precipitates (e.g., in paraproteinemia)
- Lipid droplets in severe lipemia
- Platelet satellitism / clumps (EDTA-related)
Key teaching point։
Always confirm unexpected thrombocytosis with a peripheral blood smear, especially when clinical findings do not match the report.”
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal